08/07/2020
1 réponse intégrée de Michelle Dawson
08/07/2020 23:33
Note: there are COIs, including "Drs. Wink and Erickson are inventors on a patent describing use of ketamine in autism"
Voir la réponse sur Twitter/XInfos sur le lien intégré au billet
Logan K. Wink, Debra L. Reisinger, Paul Horn, Rebecca C. Shaffer, Kaela O’Brien, Lauren Schmitt, Kelli R. Dominick, Ernest V. Pedapati, et al. (2021). Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder—Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders, 51(4), 1392-1399. Springer Science and Business Media LLC.
Plus d’infos